CLEARWATER, FL — November 19, 2018 – Bovie Medical Corporation (NYSEMKT:BVX) (the “Company”), a medical technology company and the developer of J-Plasma^®, a patented surgical product marketed and sold under the Renuvion^®Cosmetic Technology brand in the cosmetic surgery market, today announced that management will participate in the Piper Jaffray 30th Annual Healthcare Conference at the Lotte New York Palace in New York, NY. Management will participate in a fireside chat on Thursday, November 29 at 10:30 a.m. Eastern Time.

A live audio webcast of the presentation will be provided under the ‘Company Events’ section of the Bovie Medical investor relations website at http://www.boviemedical.com/investor_relations/. An archive of the webcast will be available for replay following the conferences. 

Investor Relations Contact:

Westwicke Partners on behalf of Bovie Medical Corporation
Mike Piccinino, CFA
443-213-0500
investor.relations@boviemed.com 

About Bovie Medical Corporation:

 Bovie Medical Corporation is a medical technology company and the developer of J-Plasma^®(marketed and sold under the Renuvion^®Cosmetic Technology brand in the cosmetic surgery market), a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue. J-Plasma technology utilizes a helium ionization process to produce a stable, focused beam of plasma that provides surgeons with greater precision, and minimal invasiveness.  The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Bovie Medical Corporation website at www.boviemedical.com.